SCPH scPharmaceuticals
- 5.440
- +0.130+2.45%
scPharmaceuticals所有資訊
scPharmaceuticals | 4：持股變動聲明-董事 SCHAEFFER LEONARD D
scPharmaceuticals | 4/A：持股變動聲明(修正)-高管 Nokes Rachael
scPharmaceuticals | 4：持股變動聲明-股東 ORBIMED ADVISORS LLC
scPharmaceuticals | SC 13D/A：超過5%持股股東披露文件(修正)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%)等
scPharmaceuticals | 8-K：重大事件
scPharmaceuticals | 10-Q：2024財年二季報
scPharmaceuticals | 8-K：重大事件
scPharmaceuticals | 424B5：募資說明書
scPharmaceuticals | 424B5：募資說明書
scPharmaceuticals | 8-K：重大事件
scPharmaceuticals | 4：持股變動聲明-高管 Nokes Rachael
scPharmaceuticals | SC 13G/A：超過5%持股股東披露文件(修正)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)
scPharmaceuticals | 8-K：重大事件
scPharmaceuticals | 4：持股變動聲明-董事 Khattar Jack A.
scPharmaceuticals | 4：持股變動聲明-董事 Hudson Frederick M.
scPharmaceuticals | 4：持股變動聲明-董事 Agger Mette Kirstine
scPharmaceuticals | 4：持股變動聲明-董事 SCHAEFFER LEONARD D
scPharmaceuticals | 4：持股變動聲明-董事 Abraham William Tober
scPharmaceuticals | 4：持股變動聲明-董事 VEITINGER KLAUS R DR
scPharmaceuticals | 4：持股變動聲明-董事 Baylor-Henry Minnie
分析
目標價預測
暫無數據
暫無數據